🕵️ Invivyd, Inc. ($IVVD)
SEC insider & ownership activity, last 12 months · CIK 1832038 · every row links its SEC filing
Over the last 12 months insiders sold $531K against $125K of open-market buying. Andersen Jill sold $158K through a 10b5-1 trading plan in 4 lots (Feb–Aug). Adimab, LLC trimmed 8.8% → 7.3%. One red-flag 8-K in the window: Delisting notice (3.01), Jul 23, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $125K (1 lots) · 5 sellers, $531K (20 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Andersen Jill | 0 | – | 4 | $158K | Aug 18, 2026 |
| Kevin F. McLaughlin | 1 | $125K | 0 | – | Nov 19, 2025 |
| William E. Duke | 0 | – | 4 | $95K | Aug 18, 2026 |
| Green Julie | 0 | – | 4 | $95K | Aug 18, 2026 |
| Lee Timothy Edward | 0 | – | 4 | $95K | Aug 18, 2026 |
| Robert D. Allen III | 0 | – | 4 | $88K | Aug 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 12.1% | 13G | Nov 14, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 11.6% | 13G | Sep 8, 2025 | filing ↗ | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.3% | 13G | Nov 14, 2025 | filing ↗ | |
| BVF Partners L P/IL | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| BVF INC/IL | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Mark N. Lampert | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 9.2% | 13G | Aug 14, 2026 | filing ↗ | |
| Adimab, LLC | 7.3% | 13D | Dec 23, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Peter Kolchinsky | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Rajeev Shah | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Maverick Capital, Ltd. | 6.7% | 13G | Feb 13, 2026 | filing ↗ | |
| Maverick Capital Management, LLC | 6.7% | 13G | Feb 13, 2026 | filing ↗ | |
| Lee S. Ainslie III | 6.7% | 13G | Feb 13, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Joseph Edelman | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 5.5% | 13G | Jul 28, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | 5.4% | 13G | Aug 14, 2026 | filing ↗ | |
| BVF I GP LLC | 5.4% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Lee Timothy Edward | $29K | Aug 17, 2026 | filing ↗ |
| Green Julie | $29K | Aug 17, 2026 | filing ↗ |
| William E. Duke | $29K | Aug 17, 2026 | filing ↗ |
| Andersen Jill | $49K | Aug 17, 2026 | filing ↗ |
| Robert D. Allen III | $27K | Aug 17, 2026 | filing ↗ |
| Green Julie | $62K | Feb 17, 2026 | filing ↗ |
| Robert D. Allen III | $57K | Feb 17, 2026 | filing ↗ |
| Lee Timothy Edward | $62K | Feb 17, 2026 | filing ↗ |
| William E. Duke | $62K | Feb 17, 2026 | filing ↗ |
| Andersen Jill | $103K | Feb 17, 2026 | filing ↗ |
| Adimab, LLC | $577K | Dec 23, 2025 | filing ↗ |
| Adimab, LLC | $3.7M | Nov 17, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 30, 2026 | filing ↗ |
| Other events (8.01) | Aug 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 30, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 23, 2026 | filing ↗ |
| Other events (8.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | Apr 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 9, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Other events (8.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Nov 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 24, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |